nausea photophobia

Related by string. * Nausea . nauseas . NAUSEA : bloody nausea vomiting . nausea vomiting diarrhea . diarrhea nausea vomiting . nausea vomiting rash . nausea vomiting discomfort . body aches nausea . weakness dizziness nausea . headache vomiting nausea . stiffness nausea abdominal pain . nausea fatigue . fatigue nausea / : vomiting photophobia sensitivity . photophobia * *

Related by context. Frequent words. (Click for all words.) 63 Secondary endpoints 62 P = .# 61 photophobia 61 annualized relapse 61 hypokalemia 61 erythrocyte sedimentation rate 60 hypoglycemic events 60 CI -#.# 60 Postoperative 60 Secondary endpoints included 60 dyspnea 60 placebo p = 60 paresthesia 60 symptom severity 60 achieved statistical significance 59 ocular inflammation 59 mg BID 59 #mg/day [001] 59 Response Evaluation Criteria 59 DAS# [002] 58 nasal obstruction 58 tolvaptan 58 claudication 58 plus methotrexate 58 cytogenetic response 58 Secondary endpoints include 58 creatinine clearance 58 esomeprazole 58 hypoxemia 58 fraction LVEF 57 irbesartan 57 subscales 57 RLS symptoms 57 Symptom 57 hypomagnesemia 57 sulfasalazine 57 mucosal healing 57 dose titration 57 muscle rigidity 56 diarrhea nausea vomiting 56 Solid Tumors 56 bronchodilation 56 mg QD 56 fasting plasma glucose 56 ml min 56 virologic response 56 QTc 56 oxybutynin 56 gout flares 56 composite endpoint 56 lymphopenia 56 secondary endpoint 56 dysmenorrhea 56 abdominal bloating 56 levetiracetam 56 % CI #.#-#.# [003] 56 Main Outcome Measures 56 HbA 1c 56 pramipexole 55 virologic failure 55 PANSS 55 left ventricular systolic 55 Cmax 55 concomitant medications 55 somatic symptoms 55 placebo p 55 thromboembolic events 55 angiotensin converting enzyme inhibitors 55 GERD symptoms 55 statistically significant reduction 55 Disease Activity 55 postoperatively 55 #mg dose [003] 55 myocardial ischemia 55 LVEF 55 PREZISTA r 55 Pegasys ® 55 orthostatic hypotension 55 Thrombolysis 55 J Am Coll 55 urge incontinence 55 glomerular filtration rate 55 Natalizumab 55 Negative Syndrome 55 nasopharyngitis 55 TAXUS p value 55 Monotherapy 55 EBRT 55 μg kg 55 serum uric acid 55 musculoskeletal pain 55 laboratory abnormalities 54 headache dizziness 54 IPSS 54 Ischemic 54 DOXIL 54 COPD exacerbations 54 sensory neuropathy 54 pruritus 54 dyskinesias 54 vomiting CINV

Back to home page